Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- MHLW Plans to Build Clinical Trial/Clinical Research Network with Centralized Disease-Based Patient Registry: FY2015 Preliminary Budget Request
August 22, 2014
- Report of Changes to Package Inserts to Be Required Before Providing Revised Information to Healthcare Professionals Under New System
August 21, 2014
- Health Sciences Council to Include “Program to Promote Joint Drug Development by Govt and Private Sector” in FY2015 Budget Request
August 21, 2014
- Generic Use Promotion Best Possible Way for Reducing Social Welfare Expenses: LDP Kono
August 20, 2014
- MHLW Drug Evaluation Head Eyes Flexible Designation Criteria for New Fast-Track Review System
August 19, 2014
- Emergency Use of Favipiravir to Be Permitted if Domestic Outbreak of Ebola Occurs: Health Minister
August 19, 2014
- 148 Blopress Generics OKed, Competition with AGs Likely upon December Listing
August 15, 2014
- MHLW to Lift Ban on Subcontracting of Safety Management Tasks in November
August 15, 2014
- Health Ministry Notifies Prefectures of New Regulatory Service Fees
August 14, 2014
- First Meeting of PMDA’s Panel on Placebo-Controlled Studies Set in Early October
August 13, 2014
- PMDA Will Prosper by Promoting Review Work, Research, and Training Together: Chief Executive
August 13, 2014
- Health, Science Ministries Solicit Public Comments on New Clinical Research Ethics Guidelines
August 12, 2014
- Editor’s Pick: Five Healthcare News Headlines for July 28 - August 8
August 11, 2014
- PAFSC Second Committee Supports Approval of G-CSF Drug Pegfilgrastim
August 11, 2014
- Upcoming Act on Pharmaceuticals and Medical Devices to Require “Latest Information in Package Inserts”: PFSB
August 11, 2014
- MHLW Orders Revision of Package Insert for Remicade
August 8, 2014
- Is Legal Regulation Necessary? Clinical Research at Turning Point 3: Dr Yamamoto of SCJ
August 8, 2014
- Govt to Enhance Support to Boost Pharma Sector’s Competitiveness: Health Policy Bureau Head
August 7, 2014
- Health Insurance Bureau Chief Says Discussions on Accurate Market Prices and Frequency of NHI Price Revisions Important
August 7, 2014
- MHLW Issues Notification Calling for Compliance with GVP Ministerial Ordinance
August 7, 2014
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…